BIOMAT Database Logo BIOMAT Database Logo

Heat shock protein 27 knockdown using nucleotide‑based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells. 2018

Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Department of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.

Heat shock protein 27 (Hsp27) is a chaperone protein of low molecular weight that is produced in response to various stresses and has a cytoprotective function. In the present study we found that there is a strong correlation between sensitivity to 5-fluorouracil (5-FU) and the expression of Hsp27 in colorectal cancer. Apatorsen is an antisense oligonucleotide that targets Hsp27 and has various antitumor effects in some types of cancer, such as bladder and prostate. Although several clinical studies are currently studying apatorsen in many malignancies, to date no promising results have been reported for colorectal cancer. In the present study, we examined the impact of Hsp27 downregulation (via apatorsen) on 5-FU sensitivity in colon cancer both in vitro and in vivo. In vitro, apatorsen significantly decreased the levels of Hsp27 in a dose-dependent manner in human colon cancer SW480 cells. A cell proliferation assay revealed that although apatorsen did not inhibit tumor growth, it resulted in greater 5-FU sensitivity in comparison with treatment with OGX-411 (control). In vivo, intraperitoneal injection of apatorsen decreased the levels of Hsp27 in subcutaneous tumors in a xenograft mouse model using SW480 cells and enhanced 5-FU sensitivity, compared to controls. Although further research is warranted, the present study confirmed that concurrent treatment with Hsp27 knockdown using apatorsen and 5-FU could be a promising therapy for colon cancer.

UI MeSH Term Description Entries
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006360 Heat-Shock Proteins Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. Stress Protein,Stress Proteins,Heat-Shock Protein,Heat Shock Protein,Heat Shock Proteins,Protein, Stress
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D016376 Oligonucleotides, Antisense Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize. Anti-Sense Oligonucleotide,Antisense Oligonucleotide,Antisense Oligonucleotides,Anti-Sense Oligonucleotides,Anti Sense Oligonucleotide,Anti Sense Oligonucleotides,Oligonucleotide, Anti-Sense,Oligonucleotide, Antisense,Oligonucleotides, Anti-Sense

Related Publications

Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Suppression of heat shock protein 27 expression promotes 5-fluorouracil sensitivity in colon cancer cells in a xenograft model.
October 2012, Oncology reports,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Inhibition of heat shock protein 27 phosphorylation promotes sensitivity to 5-fluorouracil in colorectal cancer cells.
December 2014, Oncology letters,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells.
January 2007, Molecular cancer therapeutics,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.
May 2009, Cancer science,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
November 2008, Oncology reports,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
June 2019, Chinese journal of integrative medicine,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Thymosin β₄ knockdown disrupts mitochondrial functions of SW480 human colon cancer cells.
September 2011, Cancer science,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Heat Shock Protein 27 Enhances SUMOylation of Heat Shock Protein B8 to Accelerate the Progression of Breast Cancer.
December 2020, The American journal of pathology,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
Knockdown of inhibitor of growth protein 2 inhibits cell invasion and enhances chemosensitivity to 5-FU in human gastric cancer cells.
November 2013, Digestive diseases and sciences,
Takehiro Shimada, and Masashi Tsuruta, and Hirotoshi Hasegawa, and Koji Okabayashi, and Kohei Shigeta, and Takashi Ishida, and Yusuke Asada, and Hirofumi Suzumura, and Kaoru Koishikawa, and Shingo Akimoto, and Yuko Kitagawa
[ADAM17 knockdown increases sensitivity of SW480 cells to cetuximad].
November 2018, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Copied contents to your clipboard!